Delivery Order SPE2DR25D2005-SPE2DR26FF1W7
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,555.46 to Amerisourcebergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with a completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract executed on January 7, 2026, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $10,083.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on January 6, 2026, with completion expected by January 7, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- On January 27, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,757.64 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML (hepatitis B vaccine) with an ultimate completion date of January 28, 2026. The contract was awarded on a firm fixed-price basis with no set-aside designation, indicating competitive award to the most qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, while its parent company Cencora, Inc....
- The Defense Logistics Agency awarded a delivery order valued at $23,145.08 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for ENGERIX-B 20 MCG/ML vaccine supply, with a ceiling value of $2,567.38. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,806.50 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML (Hepatitis B vaccine) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of ENGERIX-B 20 MCG/ML vaccine at a firm fixed price of $1,727.74. This non-set-aside delivery order, which is expected to be completed by January 8, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This delivery order, awarded on January 26, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, procures ENGERIX-B 20 MCG/ML vaccine syringes valued at $6,124.05 with a completion date of January 27, 2026. The award is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, which serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,040.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for ENGERIX-B 20 MCG/ML vaccine supply. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle...